SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the second quarter of fiscal year 2025 of $481.1 million compared to consolidated revenue for ...

Marissa Brittenham, the Chief Strategy Officer of Surgery Partners, Inc. (NASDAQ:SGRY), has recently sold shares in the company. According to a filing with the Securities and Exchange Commission, ...

The funds came from private equity firms Bain Capital and Newlight Partners and investment bank Morgan Stanley Private Credit ...

SelectQuote, Inc. (NYSE: SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced that the Company ...

SelectQuote (SLQT) announced that the company signed a $350M strategic investment from funds managed by Bain Capital, Morgan Stanley Private ...

Major stock indexes closed higher on Friday, driven by corporate earnings reports from tech firms like Alphabet and Amazon.

I Mitsubishi Chemical Group Corporation (MCG) hereby announces that it has resolved, at a meeting of the Board of Directors held today, to ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Hillenbrand sells majority stake in mechanical engineering company to Bain Capital / Net losses, weak order intake These cookies cannot be deactivated as they are required for basic functions to keep ...

Japan’s Mitsubishi Chemical Group has resolved, at a meeting of the board of directors held today, to transfer its consolidated subsidiary, Mitsubishi Tanabe Pharma (MTPC), which engages in the ...

Xiaomi's shares hit a new intraday high in Hong Kong as optimism grew over the earnings outlook for the Chinese consumer-electronics specialist this year. The South Korean internet giant posted ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.